Exact Mass: 386.2596092
Exact Mass Matches: 386.2596092
Found 144 metabolites which its exact mass value is equals to given mass value 386.2596092
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Mangalkanyl glucoside
Mangalkanyl glucoside is found in fruits. Mangalkanyl glucoside is a constituent of the root bark of Mangifera indica (mango) Constituent of the root bark of Mangifera indica (mango). Mangalkanyl glucoside is found in fruits.
Cryptomeridiol 11-rhamnoside
Cryptomeridiol 11-rhamnoside is a constituent of fruits of Cananga odorata (ylang ylang). Constituent of fruits of Cananga odorata (ylang ylang)
Glycerol trihexanoate
Glycerol trihexanoate is a probable constituent of fat Probable constituent of fats.
N-Lauroyl Tryptophan
N-lauroyl tryptophan belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Lauric acid amide of Tryptophan. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Lauroyl Tryptophan is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Lauroyl Tryptophan is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.
3-(4,8,12,16-tetramethylheptadeca-3,7,11,15-tetraenyl)thiophene-1-oxide
15,16-dihydroxy-9Z,12Z-octadecadienoic acid 2,3-dihydroxypropyl ester
Ala Ala Ile Ile
Ala Ala Ile Leu
Ala Ala Leu Ile
Ala Ala Leu Leu
Ala Ile Ala Ile
Ala Ile Ala Leu
Ala Ile Ile Ala
Ala Ile Leu Ala
Ala Leu Ala Ile
Ala Leu Ala Leu
Ala Leu Ile Ala
Ala Leu Leu Ala
Ala Val Val Val
Gly Ile Val Val
Gly Leu Val Val
Gly Val Ile Val
Gly Val Leu Val
Gly Val Val Ile
Gly Val Val Leu
Ile Ala Ala Ile
Ile Ala Ala Leu
Ile Ala Ile Ala
Ile Ala Leu Ala
Ile Gly Val Val
Ile Ile Ala Ala
Ile Leu Ala Ala
Ile Val Gly Val
Ile Val Val Gly
Leu Ala Ala Ile
Leu Ala Ala Leu
Leu Ala Ile Ala
Leu Ala Leu Ala
Leu Gly Val Val
Leu Ile Ala Ala
Leu Leu Ala Ala
Leu Val Gly Val
Leu Val Val Gly
Val Ala Val Val
Val Gly Ile Val
Val Gly Leu Val
Val Gly Val Ile
Val Gly Val Leu
Val Ile Gly Val
Val Ile Val Gly
Val Leu Gly Val
Val Leu Val Gly
Val Val Ala Val
Val Val Gly Ile
Val Val Gly Leu
Val Val Ile Gly
Val Val Leu Gly
Val Val Val Ala
Tricaproin
A triglyceride obtained by condensation of each of the three hydroxy groups of glycerol with hexanoic (caproic) acid.
Cryptomeridiol 11-rhamnoside
ascr#25
An (omega-1)-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of (2E,14R)-14-hydroxypentadec-2-enoic acid with ascarylopyranose (the alpha anomer). It is a metabolite of the nematode Caenorhabditis elegans.
oscr#25
An omega-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of (2E)-15-hydroxypentadec-2-enoic acid with ascarylopyranose (the alpha anomer). It is a metabolite of the nematode Caenorhabditis elegans.
2-ethyl-2-[[(1-oxopentyl)oxy]methyl]propane-1,3-diyl divalerate
1-(DODECYLOXY)-4-((4-ETHYNYLPHENYL)ETHYNYL)BENZENE
(2E,14R)-14-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]pentadec-2-enoic acid
(2E)-15-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]pentadec-2-enoic acid
[3-carboxy-2-[(E)-12-carboxydodec-8-enoyl]oxypropyl]-trimethylazanium
C20H36NO6+ (386.25424960000004)
[3-carboxy-2-[(E)-12-carboxydodec-10-enoyl]oxypropyl]-trimethylazanium
C20H36NO6+ (386.25424960000004)
[3-carboxy-2-[(E)-12-carboxydodec-11-enoyl]oxypropyl]-trimethylazanium
C20H36NO6+ (386.25424960000004)
[3-carboxy-2-[(E)-12-carboxydodec-6-enoyl]oxypropyl]-trimethylazanium
C20H36NO6+ (386.25424960000004)
[3-carboxy-2-[(E)-12-carboxydodec-9-enoyl]oxypropyl]-trimethylazanium
C20H36NO6+ (386.25424960000004)
1-[2-(4-methylphenyl)ethyl]-N-[3-(4-methyl-1-piperazinyl)propyl]-5-oxo-3-pyrrolidinecarboxamide
1-Cyclohexyl-4-[1-[1-[(4-fluorophenyl)methyl]-5-tetrazolyl]propyl]piperazine
C21H31FN6 (386.25940979999996)
N-[[(2R,3S,4S)-1-[cyclobutyl(oxo)methyl]-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-N-(2-methylpropyl)propanamide
N-[[(2R,3R,4R)-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-2-methoxy-N-propan-2-ylacetamide
N-[[(2S,3R,4R)-1-[cyclobutyl(oxo)methyl]-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-N-(2-methylpropyl)propanamide
N-[[(2S,3S,4S)-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-2-methoxy-N-propan-2-ylacetamide
N-[[(2S,3R,4S)-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-2-methoxy-N-propan-2-ylacetamide
N-[[(2R,3S,4R)-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-2-methoxy-N-propan-2-ylacetamide
[1-carboxy-3-[3-[(4E,7E)-deca-4,7-dienoyl]oxy-2-hydroxypropoxy]propyl]-trimethylazanium
C20H36NO6+ (386.25424960000004)
TG(18:0)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved